Evaluation of the Effect of Gabapentin in the Management of Uremic Pruritus in Hemodialysis Patients

J. Azmandian, Mosayyeb Kouhkan, S. Sohrevardi
{"title":"Evaluation of the Effect of Gabapentin in the Management of Uremic Pruritus in Hemodialysis Patients","authors":"J. Azmandian, Mosayyeb Kouhkan, S. Sohrevardi","doi":"10.18502/aptj.v3i2.13462","DOIUrl":null,"url":null,"abstract":"Background: Gabapentin is an antiepileptic agent that has analgesic properties in neuropathic pain. Given that few studies have assessed the effect of the low dose of gabapentin on uremic pruritus, this study aimed to evaluate the effect of gabapentin on pruritus of hemodialysis patients. \nMaterials and Methods: This clinical trial study was conducted on dialysis patients who were referred to Shafa Hospital, Kerman. In this regard, 40 patients consumed 100 mg of gabapentin for one week. Then patients did not take any medication within the washout period and consumed a 100 mg placebo for one week. Assessment of pruritus severity was done by visual analog scale (VAS). Hematocrit, calcium, phosphor, creatinine, and albumin were evaluated. These measurements were done before and after treatments with placebo and gabapentin. \nResults: The main places of pruritus location in dialysis patients were the back (90 %), abdomen (80%), shoulder (80%), and head (70%). The mean pruritus severity before treatment, and after treatment with placebo and gabapentin, was 8.3± 1.5, 6.73 ± 1.17, and 4.58 ± 1.50, respectively. Significant difference was seen before and after treatment, in terms of pruritus severity (p<0.1). In addition, there was a significant difference between gabapentin and placebo groups, regarding the severity of pruritus (p<0.1). No significant difference was seen before and after treatment, regarding biochemical parameters (p>0.05). \nConclusion: According to the findings, it seems that gabapentin can be an effective and safe treatment for pruritus in patients on hemodialysis. The therapeutic approach chosen for these patients is based on the neuropathic hypothesis.","PeriodicalId":429094,"journal":{"name":"Advances in Pharmacology and Therapeutics Journal","volume":"151 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Pharmacology and Therapeutics Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18502/aptj.v3i2.13462","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Gabapentin is an antiepileptic agent that has analgesic properties in neuropathic pain. Given that few studies have assessed the effect of the low dose of gabapentin on uremic pruritus, this study aimed to evaluate the effect of gabapentin on pruritus of hemodialysis patients. Materials and Methods: This clinical trial study was conducted on dialysis patients who were referred to Shafa Hospital, Kerman. In this regard, 40 patients consumed 100 mg of gabapentin for one week. Then patients did not take any medication within the washout period and consumed a 100 mg placebo for one week. Assessment of pruritus severity was done by visual analog scale (VAS). Hematocrit, calcium, phosphor, creatinine, and albumin were evaluated. These measurements were done before and after treatments with placebo and gabapentin. Results: The main places of pruritus location in dialysis patients were the back (90 %), abdomen (80%), shoulder (80%), and head (70%). The mean pruritus severity before treatment, and after treatment with placebo and gabapentin, was 8.3± 1.5, 6.73 ± 1.17, and 4.58 ± 1.50, respectively. Significant difference was seen before and after treatment, in terms of pruritus severity (p<0.1). In addition, there was a significant difference between gabapentin and placebo groups, regarding the severity of pruritus (p<0.1). No significant difference was seen before and after treatment, regarding biochemical parameters (p>0.05). Conclusion: According to the findings, it seems that gabapentin can be an effective and safe treatment for pruritus in patients on hemodialysis. The therapeutic approach chosen for these patients is based on the neuropathic hypothesis.
加巴喷丁治疗血液透析患者尿毒症性瘙痒的疗效评价
背景:加巴喷丁是一种抗癫痫药,对神经性疼痛具有镇痛作用。鉴于很少有研究评估低剂量加巴喷丁对尿毒症瘙痒的影响,本研究旨在评估加巴喷丁对血液透析患者瘙痒的影响。材料与方法:本临床试验研究对转诊至克尔曼沙法医院的透析患者进行研究。在这方面,40名患者服用100毫克加巴喷丁一周。然后,患者在洗脱期不服用任何药物,并在一周内服用100毫克安慰剂。采用视觉模拟量表(VAS)评估瘙痒严重程度。测定红细胞比容、钙、磷、肌酐和白蛋白。这些测量是在安慰剂和加巴喷丁治疗前后进行的。结果:透析患者瘙痒部位主要为背部(90%)、腹部(80%)、肩部(80%)、头部(70%)。治疗前和加巴喷丁治疗后瘙痒严重程度的平均值分别为8.3±1.5、6.73±1.17和4.58±1.50。治疗前后瘙痒严重程度差异有统计学意义(p0.05)。结论:加巴喷丁是一种安全有效的治疗血液透析患者瘙痒的药物。为这些患者选择的治疗方法是基于神经病变假说。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书